Effect of iopentol on renal function and its use for calculation of glomerular filtration rate in children

G Stake1, T Monclair, K J Berg

  • 1Department of Paediatric Radiology, National Hospital, Oslo, Norway.

Insights

Iopentol, used for pediatric urography, temporarily reduced glomerular filtration rate (GFR) by 12% in children. While tubular function showed minor changes, further research is needed before recommending iopentol as a GFR marker.

Area of Science:

  • Pediatric Nephrology
  • Radiology
  • Pharmacology

Background:

  • Glomerular filtration rate (GFR) is a key indicator of kidney function in children.
  • Accurate GFR measurement is crucial for diagnosing and managing pediatric kidney diseases.
  • Non-ionic contrast media are widely used in urography, but their effects on renal function require careful evaluation.

Purpose of the Study:

  • To investigate the impact of iopentol, a non-ionic contrast medium, on GFR in children undergoing urography.
  • To assess potential changes in renal tubular function following iopentol administration.
  • To evaluate iopentol's safety and diagnostic yield in pediatric urography.

Main Methods:

  • Nineteen children received 99mTc-DTPA for renography and subsequently iopentol for urography.
  • GFR was estimated using plasma elimination of both 99mTc-DTPA and iopentol.
  • Serum and urine biomarkers (creatinine, beta 2-microglobulin, alkaline phosphatase, N-acetyl-glucosaminidase, albumin) were analyzed.

Main Results:

  • Iopentol administration resulted in a significant GFR reduction of 12 +/- 3% without affecting serum creatinine or beta 2-microglobulin levels.
  • Urinary albumin and beta 2-microglobulin excretion remained unchanged.
  • Increased urinary excretion of alkaline phosphatase and N-acetyl-glucosaminidase indicated mild tubular effects.

Conclusions:

  • Iopentol caused transient GFR depression and mild tubular changes in children, presumed to be clinically insignificant.
  • The diagnostic yield of iopentol urography was high with few adverse events.
  • Further investigation is required to validate iopentol as a reliable GFR marker in pediatric patients.

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...